| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9954466 | Lung Cancer | 2018 | 32 Pages |
Abstract
Long-term adjuvant chemotherapy with S-1 was a feasible and promising treatment for patients with completely resected NSCLC, regardless of cisplatin addition. S-1 monotherapy should be investigated further, based on its low toxicity and practical convenience.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Tatsuro Okamoto, Tokujiro Yano, Mototsugu Shimokawa, Sadanori Takeo, Koji Yamazaki, Kenji Sugio, Mitsuhiro Takenoyama, Akira Nagashima, Shuichi Tsukamoto, Motoharu Hamatake, Hideki Yokoyama, Hitoshi Ueda, Akira Motohiro, Tetsuzo Tagawa, Fumihiro Shoji,